Tight blood sugar control in hospital: help or harm?
NCT ID NCT03510078
First seen May 07, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study looked at whether keeping blood sugar very low (under 130 mg/dL) is better than standard control (130-180 mg/dL) for non-critically ill patients with diabetes in the hospital. Researchers tracked 600 patients for complications like death, severe low blood sugar, infections, and heart issues within 30 days. The goal is to find the safest glucose target for hospitalized patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rabin Medical Center
Petah Tikva, Israel, Israel
-
Rambam Medical Center
Haifa, Israel
-
Shamir Medical Center
Ẕerifin, Israel
-
Soroka University Medical Center
Beersheba, Israel
-
Unit of Geriatric Medicine University of Modena and Reggio Emilia, University Hospital of Baggiovara
Modena, Italy
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Insulin
What this could lead to
If it works, this could help doctors choose the best blood sugar target for hospitalized patients to reduce complications like infections or heart events.
What could go wrong
This trial is completed but results may not apply to all patients. Intensive control could increase the risk of dangerously low blood sugar.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.